Welcome to Arctom, sign up to enjoy up to
20% OFF
+1 800-931-7508
[email protected]
Search in Small Molecules
Search in Biologics
Structure Search
Sign in
Register
Cart - 0 item(s)
$0.00
Your shopping cart is empty!
Building Blocks
Alcohols and Derivatives
Amines and Anilines
Amino Acids and Derivatives
Boronic Acids and Esters
Carbonyl Compounds
Halides
Heterocycles
Nitrogen Compounds
Phosphorus Compounds
Sulfur Compounds
Functional Material
Oxygen Compounds
Chemistry
Inhibitors
Natural Products
Antibodies
ADCs
Toxins
Linkers
Payloads with linkers
Miscellaneous
Material Science
Others
Catalysts
Rare Earth Metal Compounds
Transition Metal Compounds
Other
Chiral Compound
Chiral Reagents/Auxiliary
Lithium Reagent
Grignard Reagents
Silylating Reagents
Organosilicon Compounds
Inorganic Salts
Inorganic Compounds
Coupling Reagent
Oxidant
Reductant
Sugars
Rock
Tin Compounds
Our clients include world's top universities and pharmaceutical organizations
bluebird bio
Saturday, December 2, 2023
bluebird bio Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
Arcutis Biotherapeutics
Wednesday, November 29, 2023
FDA Accepts Arcutis’ Supplemental New Drug Application for Roflumilast Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to Age 6
Adaptimmune Therapeutics
Wednesday, November 29, 2023
Adaptimmune Receives Transfer of IND for Lete-cel Program
REGENXBIO
Wednesday, November 29, 2023
REGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE® Trial
XXVII World Congress and Vulvovaginal Disease Update 2024
Friday, September 13, 2024
Ljubljana, Slovenia
New England Journal of Medicine
Wednesday, November 29, 2023
Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors
New England Journal of Medicine
Wednesday, November 29, 2023
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia
New England Journal of Medicine
Wednesday, November 29, 2023
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
New England Journal of Medicine
Wednesday, November 29, 2023
Amivantamab plus Chemotherapy in NSCLC with
197
197
Launch of the LuCE Report: "Financial impact of lung cancer: A European perspective"
19
19
How to tap into biotech trends with UK companies
22
22
Going out to keep my mind off of my breast cancer diagnosis
117
117
Lung Cancer Awareness Month: Only 2.4 percent of eligible Floridians are getting lung cancer screeni
Gossamer Bio
Wednesday, November 29, 2023
Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
Karuna Therapeutics
Wednesday, November 29, 2023
Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
Amylyx Pharmaceuticals
Wednesday, November 29, 2023
Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PureTech Health
Wednesday, November 29, 2023
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
Nature
Tuesday, November 28, 2023
A stable atmospheric-pressure plasma for extreme-temperature synthesis
Nature
Tuesday, November 28, 2023
Cellular development and evolution of the mammalian cerebellum
Nature
Tuesday, November 28, 2023
MSL2 ensures biallelic gene expression in mammals
Nature
Tuesday, November 28, 2023
An autonomous laboratory for the accelerated synthesis of novel materials
1222
1222
Never Hurry for Biopsy!! #cancertreatment #cancerhealercenter #immunotherapy #cancerawareness
76
76
Engineering Football lung cancer Football... BEAT BAD VS ST JOSEPH
121
121
What if the next step in oncology was both kinder and more precise?
27947
27947
UK approves gene therapy to cure two blood disorders - BBC News
Ocugen
Wednesday, November 29, 2023
Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
Nuvalent
Wednesday, November 29, 2023
Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter 2023 Financial Results
SpringWorks Therapeutics
Wednesday, November 29, 2023
SpringWorks Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference
Precigen
Wednesday, November 29, 2023
Precigen to Participate in the JMP Securities Hematology and Oncology Summit
Nature
Tuesday, November 28, 2023
Identification of constrained sequence elements across 239 primate genomes
Nature
Tuesday, November 28, 2023
On-surface synthesis of aromatic cyclo[10]carbon and cyclo[14]carbon
Nature
Tuesday, November 28, 2023
Landscape dynamics and the Phanerozoic diversification of the biosphere
Nature
Tuesday, November 28, 2023
A resonant sextuplet of sub-Neptunes transiting the bright star HD 110067
3331
3331
U.K. approves world's first gene therapy treatment for sickle cell
1033
1033
From CRISPR to Tesla: Cathie Wood’s Guide to Revolutionary Investing
253
253
CRISPR on Demand: Fantasy or Imminent Reality?
1
1
Gunshot survivors clinic - The innovative medicine healing the whole patient
Xenon Pharmaceuticals
Wednesday, November 29, 2023
Xenon Pharmaceuticals Announces Proposed Public Offering
Avidity Biosciences
Tuesday, November 28, 2023
Avidity Biosciences to Participate in Upcoming Investor Conference
Arcturus Therapeutics
Tuesday, November 28, 2023
Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics’ ARCT-154, the First Self-Amplifying mRNA Vaccine Approved for COVID in Adults
Novocure
Tuesday, November 28, 2023
Novocure Announces Portfolio Prioritization and Strategic Restructuring Plan Focused on Near-term Growth Drivers and an Accelerated Path to Profitability
Nature
Tuesday, November 28, 2023
Exploring large-scale entanglement in quantum simulation
Nature
Tuesday, November 28, 2023
Associative pyridinium electrolytes for air-tolerant redox flow batteries
Nature
Tuesday, November 28, 2023
Scaling deep learning for materials discovery
Nature
Tuesday, November 28, 2023
The genetic legacy of the expansion of Bantu-speaking peoples in Africa
1541
1541
New lung cancer screening guidelines make millions more eligible for testing
1389
1389
FDA considers 1st CRISPR gene editing treatment that may cure sickle cell disease
391
391
Mar's Inspiring Journey: Battling Multiple Myeloma with CAR-T Treatment | IMF Patient Story 2023
213
213
Novartis CEO: Company set to become a pure play, innovative medicine business after Sandoz spin off
Not More
Show More
loading...